Clinical Trials Directory

Trials / Completed

CompletedNCT01694914

Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
122 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

At present, all commercially available corneal organ culture media contain foetal calf serum (FCS) and sometimes other compounds extracted from animals. These compounds are necessary for corneal cell survival but are problematic because they theoretically have risk of anthropozoonosis transmission, especially for new variant of CJD and the variability between FCS batches influence graft quality. Our laboratory research allowed in vitro and ex vivo validation of a new medium free compound animal. We proved its superiority over conventional medium containing 2% FCS for endothelial cell survival during the storage time. The goal of this clinical trial is now to assess its superiority in patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREcorneal graft

Timeline

Start date
2012-01-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2012-09-27
Last updated
2015-01-30

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01694914. Inclusion in this directory is not an endorsement.

Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium (NCT01694914) · Clinical Trials Directory